Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies.
about
RNase 7 in Cutaneous DefenseNanoparticle-Enabled Transdermal Drug Delivery Systems for Enhanced Dose Control and Tissue TargetingNucleic acid delivery into skin for the treatment of skin disease: Proofs-of-concept, potential impact, and remaining challenges.Noninvasive approach for enhancing small interfering RNA delivery percutaneously.Tissue-engineered human psoriatic skin supplemented with cytokines as an in vitro model to study plaque psoriasis.Towards the development of a RNAi-based topical treatment for psoriasis: Proof-of-concept in a 3D psoriasis skin model.Topically applied lipid- and surfactant-based nanoparticles in the treatment of skin disorders.Friends or Foes? Host defense (antimicrobial) peptides and proteins in human skin diseases.Advances in the Application and Impact of MicroRNAs as Therapies for Skin DiseaseContribution of In Vivo and Organotypic 3D Models to Understanding the Role of Macrophages and Neutrophils in the Pathogenesis of Psoriasis.Hair pigmentation disorders or 50 years of German-Polish alliance for study on a severe side effect of chemotherapy: Kostanecki's legacy.Efficient delivery of nucleic acid molecules into skin by combined use of microneedle roller and flexible interdigitated electroporation array.
P2860
Q26752767-C9AFD409-2538-4505-9824-AA08ACBD9981Q28079462-7099CDBC-626D-4139-997B-3E0D5AD7FC72Q28085200-88980E1B-E87D-4871-A59C-C87170463342Q35848069-A70A2C1E-5C9F-4363-9566-C717707AD199Q38443852-0F8A0782-C089-41B8-8E83-8B3E8AF49748Q38638229-F3EB92E9-1FD8-4C7A-9DD4-2665BF53DCFFQ38878423-F7E43C93-746E-4F5E-ABF8-FDA36AD25420Q39133115-08E249A0-89AC-48AB-B369-C15514B813C8Q42362861-D1ACB930-194A-405D-B7B9-6253A2FF85E1Q47294822-8ABA9D50-998C-48F3-B2E8-E456550B692AQ48063896-1E28E97E-BDC7-4688-860D-D00CABFA7F1BQ55002159-37E8A96D-380A-4D70-8007-6C64A7C86C9F
P2860
Targeted silencing of DEFB4 in a bioengineered skin-humanized mouse model for psoriasis: development of siRNA SECosome-based novel therapies.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@en
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@nl
type
label
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@en
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@nl
prefLabel
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@en
Targeted silencing of DEFB4 in ...... ECosome-based novel therapies.
@nl
P2093
P50
P356
P1476
Targeted silencing of DEFB4 in ...... SECosome-based novel therapies
@en
P2093
Eline Desmet
Jo Lambert
Marcela Del Rio
Nuria Illera
Stefanie Bracke
P304
P356
10.1111/EXD.12321
P577
2014-03-01T00:00:00Z